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Dual- or multi-target ligands have gained increased
attention in the past years due to several advantages,
including more simple pharmacokinetic and phamarco-
dynamic properties compared to a combined application
of several drugs. Furthermore multi-target ligands often
possess improved efficacy [1]. We present a new
approach for the discovery of dual-target ligands using
aligned pharmacophore models combined with a shape-
based scoring. Starting with two sets of known active
compounds for each target, a number of different phar-
macophore models is generated and subjected to pairwise
graph-based alignment using the Kabsch-Algorithm [2,3].
S i n c eac o m p o u n dm a yb ea b l et ob i n dt od i f f e r e n tt a r -
gets in different conformations, the algorithm aligns pairs
of pharmacophore models sharing the same features
which are not necessarily at the exactly same spatial dis-
tance. Using the aligned models, a pharmacophore search
on a multi-conformation-database is performed to find
compounds matching both models. The potentially
“dual” ligands are scored by a shape-based comparison
with the known active molecules using ShaEP [4].
Using this approach, we performed a prospective frag-
ment-based virtual screening for dual 5-LO/sEH inhibi-
tors. Both enzymes play an important role in the
arachidonic acid cascade and are involved in inflamma-
tory processes, pain, cardiovascular diseases and allergic
reactions [5,6]. Beside several new selective inhibitors
we were able to find a compound inhibiting both
enzymes in low micromolar concentrations. The results
indicate that the idea of aligned pharmacophore models
can be successfully employed for the discovery of dual-
target ligands.
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